These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15374707)

  • 41. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of raloxifene hydrochloride on the endometrium of postmenopausal women.
    Boss SM; Huster WJ; Neild JA; Glant MD; Eisenhut CC; Draper MW
    Am J Obstet Gynecol; 1997 Dec; 177(6):1458-64. PubMed ID: 9423751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK; Bunyavejchevin S
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.
    Walsh BW; Paul S; Wild RA; Dean RA; Tracy RP; Cox DA; Anderson PW
    J Clin Endocrinol Metab; 2000 Jan; 85(1):214-8. PubMed ID: 10634389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study.
    Sgarabotto M; Baldini M; Dei Cas A; Manotti C; Luciana Barilli A; Rinaldi M; Benassi L; Bacchi Modena A
    Thromb Res; 2007; 119(1):85-91. PubMed ID: 16499954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women.
    De Leo V; la Marca A; Morgante G; Lanzetta D; Setacci C; Petraglia F
    Am J Obstet Gynecol; 2001 Feb; 184(3):350-3. PubMed ID: 11228485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosis.
    Hayashi T; Ina K; Maeda M; Nomura H
    Nitric Oxide; 2011 May; 24(4):199-203. PubMed ID: 21513812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy.
    Vitale C; Cornoldi A; Gebara O; Silvestri A; Wajngarten M; Cerquetani E; Fini M; Ramires JA; Rosano GM
    Menopause; 2005; 12(5):552-8. PubMed ID: 16145309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers.
    Eilertsen AL; Sandvik L; Steinsvik B; Sandset PM
    J Thromb Haemost; 2008 Jun; 6(6):928-34. PubMed ID: 18394014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiplatelet therapy use and the risk of venous thromboembolic events in the Raloxifene Use for the Heart (RUTH) trial.
    Duvernoy CS; Yeo AA; Wong M; Cox DA; Kim HM
    J Womens Health (Larchmt); 2010 Aug; 19(8):1459-65. PubMed ID: 20626269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
    Uebelhart B; Herrmann F; Pavo I; Draper MW; Rizzoli R
    J Bone Miner Res; 2004 Sep; 19(9):1518-24. PubMed ID: 15312253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
    Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial.
    Ensrud KE; Stock JL; Barrett-Connor E; Grady D; Mosca L; Khaw KT; Zhao Q; Agnusdei D; Cauley JA
    J Bone Miner Res; 2008 Jan; 23(1):112-20. PubMed ID: 17892376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women.
    Hemelaar M; Kenemans P; de Bie L; van de Weijer PH; van der Mooren MJ
    Fertil Steril; 2006 Apr; 85(4):979-88. PubMed ID: 16580384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone, and raloxifene.
    Sioulas V; Christodoulakos G; Lambrinoudaki I; Politi E; Sergentanis TN; Creatsas G
    Fertil Steril; 2008 Apr; 89(4):1018-20. PubMed ID: 17689538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.
    Vogelvang TE; Mijatovic V; van der Mooren MJ; Pinsdorf U; von Bergmann K; Netelenbos JC; Lütjohann D
    Maturitas; 2005 Apr; 50(4):312-20. PubMed ID: 15780532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of hormone therapies on the urinary excretion of prostacyclin and thromboxane A2.
    Bruce D; Frick A; Rymer J; Robinson J; Ylikorkala O
    Climacteric; 2008; 11(6):447-53. PubMed ID: 18821092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Homocysteine in postmenopausal women and the importance of hormone replacement therapy.
    Mijatovic V; van der Mooren MJ
    Clin Chem Lab Med; 2001 Aug; 39(8):764-7. PubMed ID: 11592448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.